CannBioRx Life Sciences Corp (ATNFW) Key Ratios
$0.43
As on 15-Aug-2025 16:28EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -71.36 | -- | -- |
| EBIT | -- | -- | 47.70 | -168.78 | -213.92 |
| Net Profit | 27.12 | -14,755.84 | 26.66 | -172.82 | 11.52 |
| EPS | 88.31 | -2,459.83 | 70.47 | -319.95 | -- |
| Book Value | -- | -- | -- | 32.04 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-24 | Dec-23 |
| EBIT-Margin
| -- | -- | -8,166.26 | -- | -- |
| Net Margin
| -- | -- | -9,678.50 | -- | -- |
| Return on equity
| -50,955,821.48 | -42,252,726.51 | -125.82 | -135.20 | -355.47 |
| Return on Capital
| -47,842,371.20 | -39,495,094.51 | -- | -119.39 | -292.95 |
| Return on Assets
| -31,345,726.82 | -25,682,757.45 | -76.79 | -68.45 | -160.06 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.02 | -8.25 |
The underlying data is unavailable.